Search results for "Medium spiny neuron"

showing 10 items of 15 documents

Neuropeptide Y (NPY) in cerebrospinal fluid from patients with Huntington's Disease: increased NPY levels and differential degradation of the NPY1-30…

2016

Huntington's disease (HD) is an inherited and fatal polyglutamine neurodegenerative disorder caused by an expansion of the CAG triplet repeat coding region within the HD gene. Progressive dysfunction and loss of striatal GABAergic medium spiny neurons (MSNs) may account for some of the characteristic symptoms in HD patients. Interestingly, in HD, MSNs expressing neuropeptide Y (NPY) are spared and their numbers is even up-regulated in HD patients. Consistent with this, we report here on increased immuno-linked NPY (IL-NPY) levels in human cerebrospinal fluid (hCSF) from HD patients (Control n = 10; early HD n = 9; mid HD n = 11). As this antibody-based detection of NPY may provide false pos…

0301 basic medicineAdultMalemedicine.medical_specialtyCathepsin DDynorphinMedium spiny neuronBiochemistry03 medical and health sciencesCellular and Molecular NeuroscienceMice0302 clinical medicineCerebrospinal fluidHuntington's diseaseInternal medicinemental disordersmedicineAnimalsHumansNeuropeptide YNeprilysinAgedThimet oligopeptidaseChemistryMiddle Agedmedicine.diseaseNeuropeptide Y receptorPeptide FragmentsRats030104 developmental biologyEndocrinologyHEK293 CellsHuntington DiseaseProteolysisFemale030217 neurology & neurosurgeryBiomarkersJournal of neurochemistry
researchProduct

ESC-Derived BDNF-Overexpressing Neural Progenitors Differentially Promote Recovery in Huntington's Disease Models by Enhanced Striatal Differentiation

2016

Summary Huntington's disease (HD) is characterized by fatal motoric failures induced by loss of striatal medium spiny neurons. Neuronal cell death has been linked to impaired expression and axonal transport of the neurotrophin BDNF (brain-derived neurotrophic factor). By transplanting embryonic stem cell-derived neural progenitors overexpressing BDNF, we combined cell replacement and BDNF supply as a potential HD therapy approach. Transplantation of purified neural progenitors was analyzed in a quinolinic acid (QA) chemical and two genetic HD mouse models (R6/2 and N171-82Q) on the basis of distinct behavioral parameters, including CatWalk gait analysis. Explicit rescue of motor function by…

0301 basic medicineGene ExpressionBiochemistrychemistry.chemical_compoundMice0302 clinical medicineNeural Stem CellsNeurotrophic factorsGenes Reporterlcsh:QH301-705.5Neuronslcsh:R5-920NeurogenesisCell DifferentiationAnatomyembryonic stem cellsHuntington Diseaselcsh:Medicine (General)NeurogliaLocomotionNeurotrophinHuntington’s diseaseCell SurvivalBiologyMedium spiny neuronArticle03 medical and health sciencesHuntington's diseaseGeneticsmedicinestriatal differentiationAnimalsBrain-derived neurotrophic factorBrain-Derived Neurotrophic FactorCell Biologymedicine.diseaseCorpus StriatumTransplantationDisease Models Animal030104 developmental biologylcsh:Biology (General)chemistrynervous systembiology.proteinNeuroscience030217 neurology & neurosurgeryBiomarkersDevelopmental BiologyQuinolinic acidStem Cell TransplantationStem Cell Reports
researchProduct

Tetrahydrocarbazoles decrease elevated SOCE in medium spiny neurons from transgenic YAC128 mice, a model of Huntington's disease

2017

AbstractHuntington's disease (HD) is a hereditary neurodegenerative disease caused by a polyglutamine expansion within the huntingtin (HTT) gene. One of the cellular functions that is dysregulated in HD is store-operated calcium entry (SOCE), a process in which the depletion of Ca2+ from the endoplasmic reticulum (ER) induces Ca2+ influx from the extracellular space. We detected an enhanced activity of SOC channels in medium spiny neurons (MSNs) from YAC128 mice, a transgenic model of HD, and investigated whether this could be reverted by tetrahydrocarbazoles. The compound 6-bromo-N-(2-phenylethyl)-2,3,4,9-tetrahydro-1H-carbazol-1-amine hydrochloride was indeed able to restore the disturbed…

0301 basic medicineHuntingtinTransgeneCarbazolesBiophysicsMice TransgenicBiologyEndoplasmic ReticulumMedium spiny neuronYAC128BiochemistryMice03 medical and health sciences0302 clinical medicineHuntington's diseaseTetrahydrocarbazolesmedicineAnimalsHomeostasisHuntingtinMolecular BiologyCells CulturedMembrane Potential MitochondrialNeuronsSOC channelsMedium spiny neuronsIon TransportEndoplasmic reticulumHuntington's diseaseStore-operated calcium entryCell Biologymedicine.diseaseStore-operated calcium entryCulture MediaCell biology030104 developmental biologyBiochemistryCalcium030217 neurology & neurosurgeryHomeostasisBiochemical and Biophysical Research Communications
researchProduct

Dopaminergic-GABAergic interplay and alcohol binge drinking

2019

© 2019 Elsevier Ltd The dopamine D 3 receptor (D 3 R), in the nucleus accumbens (NAc), plays an important role in alcohol reward mechanisms. The major neuronal type within the NAc is the GABAergic medium spiny neuron (MSN), whose activity is regulated by dopaminergic inputs. We previously reported that genetic deletion or pharmacological blockade of D 3 R increases GABA A α6 subunit in the ventral striatum. Here we tested the hypothesis that D 3 R-dependent changes in GABA A α6 subunit in the NAc affect voluntary alcohol intake, by influencing the inhibitory transmission of MSNs. We performed in vivo and ex vivo experiments in D 3 R knockout (D 3 R −/− ) mice and wild type littermates (D 3 …

0301 basic medicineMalemedicine.medical_specialtyDopaminergic-GABAergicSettore BIO/09 - FISIOLOGIAAlpha6 subunit; Dopamine D3 receptor; Ethanol; Furosemide (PubChem CID: 3440); GABA(A)receptor; Nucleus accumbens; Ro 15-4513; Ro 15-4513 (PubChem CID: 5081); SB 277011A (PubChem CID: 75358288)Alpha6 subunitNucleus accumbensMedium spiny neuronInhibitory postsynaptic potentialNucleus AccumbensBinge Drinking03 medical and health sciencesMiceDopamine D3 receptor0302 clinical medicineDopamine receptor D3Internal medicinemedicineAnimalsFurosemide (PubChem CID: 3440)Nucleus accumbenPharmacology & PharmacyRNA MessengerRo 15-4513GABAergic NeuronsSB 277011A (PubChem CID: 75358288).PharmacologyMice KnockoutEthanolGABAA receptorChemistryDopaminergicAntagonistReceptors Dopamine D3Receptors GABA-ARo 15-4513 (PubChem CID: 5081)GABA(A)receptor3. Good healthProtein Subunits030104 developmental biologyEndocrinologynervous systemGene Expression Regulation030220 oncology & carcinogenesisGABAergicNucleus accumbensSB 277011A (PubChem CID: 75358288)
researchProduct

2018

Haplotypes of the Gabra2 gene encoding the α2-subunit of the GABAA receptor (GABAAR) are associated with drug abuse, suggesting that α2-GABAARs may play an important role in the circuitry underlying drug misuse. The genetic association of Gabra2 haplotypes with cocaine addiction appears to be evident primarily in individuals who had experienced childhood trauma. Given this association of childhood trauma, cocaine abuse and the Gabra2 haplotypes, we have explored in a mouse model of early life adversity (ELA) whether such events influence the behavioral effects of cocaine and if, as suggested by the human studies, α2-GABAARs in the nucleus accumbens (NAc) are involved in these perturbed beha…

0301 basic medicinePharmacologymedicine.medical_specialtyGABAA receptorAddictionmedia_common.quotation_subjectBiologyNucleus accumbens16. Peace & justiceInhibitory postsynaptic potentialMedium spiny neuronmedicine.diseaseSubstance abuse03 medical and health sciencesCellular and Molecular Neuroscience030104 developmental biology0302 clinical medicineEndocrinologyInternal medicinemedicinebiology.proteinGABRA2030217 neurology & neurosurgerymedia_commonGenetic associationNeuropharmacology
researchProduct

Endocannabinoid LTD in Accumbal D1 Neurons Mediates Reward-Seeking Behavior

2020

Summary The nucleus accumbens (NAc) plays a key role in drug-related behavior and natural reward learning. Synaptic plasticity in dopamine D1 and D2 receptor medium spiny neurons (MSNs) of the NAc and the endogenous cannabinoid (eCB) system have been implicated in reward seeking. However, the precise molecular and physiological basis of reward-seeking behavior remains unknown. We found that the specific deletion of metabotropic glutamate receptor 5 (mGluR5) in D1-expressing MSNs (D1miRmGluR5 mice) abolishes eCB-mediated long-term depression (LTD) and prevents the expression of drug (cocaine and ethanol), natural reward (saccharin), and brain-stimulation-seeking behavior. In vivo enhancement…

0301 basic medicineglutamate02 engineering and technologyMolecular neuroscienceBiologyNucleus accumbensMGLUR5 receptorsMedium spiny neuronArticleinduced reinstatementBehavioral Neuroscience03 medical and health sciencesDopamineDopamine receptor D2lipasemedicinelong-term depression[SDV.NEU] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]lcsh:ScienceLong-term depressionrelapseMultidisciplinaryMetabotropic glutamate receptor 5021001 nanoscience & nanotechnologyEndocannabinoid systemin-vivo exposure3. Good healthrats030104 developmental biologynervous systemethanol-seekingplasticitylcsh:Q[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]Molecular Neuroscience0210 nano-technologyNeurosciencepsychological phenomena and processesNeurosciencemedicine.drugiScience
researchProduct

Circuit Specific Functions of Cannabinoid CB1 Receptor in the Balance of Investigatory Drive and Exploration

2011

Well balanced novelty seeking and exploration are fundamental behaviours for survival and are found to be dysfunctional in several psychiatric disorders. Recent studies suggest that the endocannabinoid (eCB) system is an important control system for investigatory drive. Pharmacological treatment of rodents with cannabinergic drugs results in altered social and object investigation. Interestingly, contradictory results have been obtained, depending on the treatment, drug concentration and experimental conditions. The cannabinoid type 1 (CB1) receptor, a central component of the eCB system, is predominantly found at the synapses of two opposing neuronal populations, i.e. on inhibitory GABAerg…

Cannabinoid receptorMousemedicine.medical_treatmentScienceGlutamic AcidNeural HomeostasisMice TransgenicBiologyMedium spiny neuronSynaptic Transmissiongamma-Aminobutyric acidGlutamatergicBehavioral NeuroscienceMiceModel OrganismsReceptor Cannabinoid CB1medicineGeneticsAnimalsGABAergic NeuronsSocial BehaviorBiologygamma-Aminobutyric AcidPsychiatryNeuronsMultidisciplinaryBehavior AnimalMood DisordersQRAnimal ModelsNeurotransmittersEndocannabinoid systemMice Inbred C57BLMental Healthnervous systemDopamine receptorMaladjustmentExploratory BehaviorGABAergicMedicineCannabinoidNeuroscienceAnimal Geneticsmedicine.drugResearch ArticleNeurosciencePLoS ONE
researchProduct

Pre- and postsynaptic type-1 cannabinoid receptors control the alterations of glutamate transmission in experimental autoimmune encephalomyelitis

2013

Type-1 cannabinoid receptors (CB1R) are important regulators of the neurodegenerative damage in multiple sclerosis (MS) and in experimental autoimmune encephalomyelitis (EAE). In GABAergic striatal neurons, CB1R stimulation exerts protective effects by limiting inflammation-induced potentiation of glutamate-mediated spontaneous excitatory postsynaptic currents (sEPSCs). Here we show that CB1R located on GABAergic or on glutamatergic neurons are differentially involved in the pre- and postsynaptic alterations of sEPSCs caused by EAE in the striatum. After induction of EAE, mice selectively lacking CB1R on GABAergic neurons (GABA-CB1R-KO) showed exacerbated alterations of sEPSC duration in GA…

Encephalomyelitis Autoimmune ExperimentalTime FactorsPostsynaptic CurrentPresynaptic TerminalsExcitotoxicityGlutamic AcidIn Vitro TechniquesBiologyMedium spiny neuronmedicine.disease_causeSynaptic TransmissionMiceCellular and Molecular NeuroscienceGlutamatergicReceptor Cannabinoid CB1Postsynaptic potentialmedicineAnimalsgamma-Aminobutyric AcidMice KnockoutNeuronsPharmacologyExperimental autoimmune encephalomyelitisGlutamate receptorExcitatory Postsynaptic Potentialsmedicine.diseaseCorpus StriatumMice Inbred C57BLnervous systemDisease ProgressionExcitatory postsynaptic potentialFemaleSettore MED/26 - NeurologiaNeuroscience
researchProduct

Dopamine restores limbic memory loss, dendritic spine structure, and NMDAR-dependent LTD in the nucleus accumbens of alcohol-withdrawn rats

2018

Alcohol abuse leads to aberrant forms of emotionally salient memory, i.e., limbic memory, that promote escalated alcohol consumption and relapse. Accordingly, activity-dependent structural abnormalities are likely to contribute to synaptic dysfunctions that occur from suddenly ceasing chronic alcohol consumption. Here we show that alcohol-dependent male rats fail to perform an emotional-learning task during abstinence but recover their functioning byl-3,4-dihydroxyphenylalanin (l-DOPA) administration during early withdrawal.l-DOPA also reverses the selective loss of dendritic “long thin” spines observed in medium spiny neurons of the nucleus accumbens (NAc) shell of alcohol-dependent rats d…

Male0301 basic medicineDendritic spineDendritic SpinesAlcohol abuseDopamineDopamine AgentsAMPA receptorMotor ActivityNucleus accumbensMedium spiny neuronReceptors N-Methyl-D-AspartateNucleus AccumbensLevodopaRats Sprague-Dawley03 medical and health sciences0302 clinical medicineDopamineMemoryLimbic SystemmedicineAnimalsReceptors AMPAResearch ArticlesMemory DisordersAlcohol Abstinencebusiness.industryLong-Term Synaptic DepressionGeneral NeuroscienceDopaminergicRatsConfocal microscopyAlcoholism030104 developmental biologySynaptic plasticityLTDSettore BIO/14 - FarmacologiaNMDA receptorGlutamatebusinessNeuroscience030217 neurology & neurosurgerymedicine.drug
researchProduct

Causal Link between n-3 Polyunsaturated Fatty Acid Deficiency and Motivation Deficits

2020

International audience; Reward-processing impairment is a common symptomatic dimension of several psychiatric disorders. However, whether the underlying pathological mechanisms are common is unknown. Herein, we asked if the decrease in the n-3 polyunsaturated fatty acid (PUFA) lipid species, consistently described in these pathologies, could underlie reward-processing deficits. We show that reduced n-3 PUFA biostatus in mice leads to selective motivational impairments. Electrophysiological recordings revealed increased collateral inhibition of dopamine D2 receptor-expressing medium spiny neurons (D2-MSNs) onto dopamine D1 receptor-expressing MSNs in the nucleus accumbens, a main brain regio…

Male0301 basic medicineN-3 PUFAPhysiology[SDV]Life Sciences [q-bio]DopamineMice TransgenicNucleus accumbensMedium spiny neuronMice03 medical and health sciences0302 clinical medicineDopamineDopamine receptor D2Fatty Acids Omega-3medicineAnimalsMolecular BiologyPathological030304 developmental biologyNeuronsMedium spiny neuronschemistry.chemical_classification[SDV.GEN]Life Sciences [q-bio]/Genetics0303 health sciencesMotivationReceptors Dopamine D2business.industry[SCCO.NEUR]Cognitive science/NeuroscienceCell BiologyMice Inbred C57BLElectrophysiology[SDV.GEN.GA]Life Sciences [q-bio]/Genetics/Animal geneticsElectrophysiology030104 developmental biologychemistryNucleus accumbensFemalePolyunsaturated fatty acids[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]Causal linkbusinessNeuroscience030217 neurology & neurosurgerymedicine.drugPolyunsaturated fatty acidCell Metabolism
researchProduct